Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yvonne E. Fillié-Grijpma"'
Autor:
Jana Koers, Rocco Sciarrillo, Ninotska I.L. Derksen, Esther M. Vletter, Yvonne E. Fillié-Grijpma, Elisabeth Raveling-Eelsing, Nuno A.G. Graça, Thiemo Leijser, Hendri H. Pas, L. Laura van Nijen-Vos, Maaike V.J. Braham, Anne-Marie Buisman, Jan de Jong, Angela I. Schriek, Anne P. Tio-Gillen, Y.K. Onno Teng, Maurice Steenhuis, Francis H. Swaneveld, Steven W. de Taeye, Marit J. van Gils, Jan J.G.M. Verschuuren, Bram Rutgers, Peter Heeringa, Barbara Horváth, Bart C. Jacobs, Karina de Leeuw, Casper F.M. Franssen, Agnès Veyradier, Paul Coppo, Kyra A. Gelderman, S. Marieke van Ham, Cécile A.C.M. van Els, Diane van der Woude, Ruth Huizinga, Maartje G. Huijbers, Taco W. Kuijpers, Rene E.M. Toes, Nicolaas A. Bos, Theo Rispens
Publikováno v:
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. MOSBY-ELSEVIER
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. Mosby Inc.
Journal of allergy and clinical immunology, 151(6), 1646-1654. Mosby Inc.
T2B Consortium 2023, ' Differences in IgG autoantibody Fab glycosylation across autoimmune diseases ', Journal of Allergy and Clinical Immunology, vol. 151, no. 6, pp. 1646-1654 . https://doi.org/10.1016/j.jaci.2022.10.035
Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. Mosby Inc.
Journal of allergy and clinical immunology, 151(6), 1646-1654. Mosby Inc.
T2B Consortium 2023, ' Differences in IgG autoantibody Fab glycosylation across autoimmune diseases ', Journal of Allergy and Clinical Immunology, vol. 151, no. 6, pp. 1646-1654 . https://doi.org/10.1016/j.jaci.2022.10.035
Background: Increased prevalence of autoantibody Fab glycosylation has been demonstrated for several autoimmune diseases. Objectives: To study whether elevated Fab glycosylation is a common feature of autoimmunity, this study investigated Fab glycosy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5813e3dc93eee892ef693f3c417e2f1
https://research.rug.nl/en/publications/53202de0-8a76-4930-ae74-692d30576434
https://research.rug.nl/en/publications/53202de0-8a76-4930-ae74-692d30576434
Autor:
Paul W. H. I. Parren, Dana L.E. Vergoossen, Yvonne E. Fillié-Grijpma, Jan J.G.M. Verschuuren, Elena Domínguez-Vega, Jaap J. Plomp, Silvère M. van der Maarel, Maartje G. Huijbers, Robyn Verpalen, Christoph Gstöttner, Roy Augustinus, Manfred Wuhrer
Publikováno v:
Proceedings of the National Academy of Sciences, 118(13). NATL ACAD SCIENCES
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America
Significance An expanding group of autoimmune diseases is now recognized to be hallmarked by pathogenic IgG4 autoantibodies. IgG4 has the unique ability to exchange Fab-arms, rendering it bispecific and functionally monovalent. Here we show that auto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7654bd0987b9454f7e87bee22fd27e7
http://hdl.handle.net/1887/3196550
http://hdl.handle.net/1887/3196550
Autor:
Jan J.G.M. Verschuuren, Yvonne E. Fillié-Grijpma, Erik H. Niks, Jaap J. Plomp, Inge E. van Es, Steve Burden, Silvère M. van der Maarel, Mario Losen, Wei Zhang, Maartje G. Huijbers
Publikováno v:
Annals of the New York Academy of Sciences. 1413:111-118
Myasthenia gravis (MG) with antibodies to muscle-specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6a1d377f8931630fdefe465b6071923
https://doi.org/10.1111/nyas.13543
https://doi.org/10.1111/nyas.13543
Autor:
Inge E. van Es, Jan J.G.M. Verschuuren, Hans de Haard, Maartje G. Huijbers, Samar Kamar-Al Majidi, Jaap J. Plomp, Peter Ulrichts, Silvère M. van der Maarel, Yvonne E. Fillié-Grijpma, Erik G. Hofman
Publikováno v:
Experimental Neurology, 317, 133-143
Myasthenia gravis is hallmarked by fatigable muscle weakness resulting from neuromuscular synapse dysfunction caused by IgG autoantibodies. The variant with muscle-specific kinase (MuSK) autoantibodies is characterized by prominent cranial and bulbar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0546ae73f29033123e474eaf80edd87a
https://hdl.handle.net/1887/120816
https://hdl.handle.net/1887/120816
Autor:
Jan J G M, Verschuuren, Jaap J, Plomp, Steve J, Burden, Wei, Zhang, Yvonne E, Fillié-Grijpma, Inge E, Stienstra-van Es, Erik H, Niks, Mario, Losen, Silvère M, van der Maarel, Maartje G, Huijbers
Publikováno v:
Annals of the New York Academy of Sciences. 1413(1)
Myasthenia gravis (MG) with antibodies to muscle-specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8fd422d22ab88e1afada4d1f70bfdbf
https://pubmed.ncbi.nlm.nih.gov/29356029
https://pubmed.ncbi.nlm.nih.gov/29356029